146 related articles for article (PubMed ID: 21388481)
1. Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.
LoPiccolo MC; Sage RJ; Kouba DJ
Dermatol Surg; 2011 Jul; 37(7):1047-50. PubMed ID: 21388481
[No Abstract] [Full Text] [Related]
2. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
[No Abstract] [Full Text] [Related]
3. [Carbon dioxide-laser treatment of trichoepitheliomas in Brooke-Spiegler syndrome].
Allende I; Truchuelo MT; Alcántara J; Boixeda P
Actas Dermosifiliogr; 2011 Jan; 102(1):76-7. PubMed ID: 21315872
[No Abstract] [Full Text] [Related]
4. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
6. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
7. Nodular basal cell carcinoma: when in doubt, cut it out.
Brownell I
J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
[TBL] [Abstract][Full Text] [Related]
8. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
Nijsten T
Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
[No Abstract] [Full Text] [Related]
9. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
Arits A; Nelemans P; Kelleners-Smeets N
Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
[No Abstract] [Full Text] [Related]
10. Radiofrequency ablation: a safe and economical modality in treatment of Brooke-Spiegler syndrome.
Chaudhary S; Dayal S
Dermatol Online J; 2012 Aug; 18(8):7. PubMed ID: 22948057
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy in a teenage girl with xeroderma pigmentosum type C.
Larson DM; Cunningham BB
Pediatr Dermatol; 2012; 29(3):373-4. PubMed ID: 22277026
[TBL] [Abstract][Full Text] [Related]
12. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
Sebaratnam DF; Venugopal SS; Murrell DF
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
[No Abstract] [Full Text] [Related]
13. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
[No Abstract] [Full Text] [Related]
14. Effect of pigmentation on photodynamic therapy.
Apalla Z; Lallas A; Sotiriou E; Ioannides D
Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
[No Abstract] [Full Text] [Related]
15. Effect of pigmentation on photodynamic therapy - Authors' reply.
Arits A; Kelleners-Smeets NW
Lancet Oncol; 2013 Aug; 14(9):e340. PubMed ID: 23896273
[No Abstract] [Full Text] [Related]
16. Fractionated aminolevulinic acid-photodynamic therapy (PDT) provides additional evidence for the use of PDT for non-melanoma skin cancer.
Gold MH
J Eur Acad Dermatol Venereol; 2009 May; 23(5):571-2. PubMed ID: 19415805
[No Abstract] [Full Text] [Related]
17. Brooke-Spiegler syndrome - report of four families: treatment with CO2 laser.
Retamar RA; Stengel F; Saadi ME; Kien MC; Della Giovana P; Cabrera H; Chouela EN
Int J Dermatol; 2007 Jun; 46(6):583-6. PubMed ID: 17550556
[TBL] [Abstract][Full Text] [Related]
18. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
19. Enucleation of cylindromas in Brooke-Spiegler syndrome: a novel surgical technique.
Brass D; Rajan N; Langtry J
Dermatol Surg; 2014 Dec; 40(12):1438-9. PubMed ID: 25361203
[No Abstract] [Full Text] [Related]
20. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
